IGM Biosciences Inc [NASDAQ: IGMS] closed the trading session at $212800.0 on 2025-07-01. The day’s price range saw the stock hit a low of $1.29, while the highest price level was $1.39.
The stocks have a year to date performance of -80.48 percent and weekly performance of 9.32 percent. The stock has been moved at -80.60 percent over the last six months. The stock has performed 1.57 percent around the most recent 30 days and changed 12.17 percent over the most recent 3-months.
If compared to the average trading volume of 212.80K shares, IGMS reached to a volume of 13460719 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about IGM Biosciences Inc [IGMS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IGMS shares is $1.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IGMS stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stifel have made an estimate for IGM Biosciences Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, RBC Capital Mkts dropped their target price from $20 to $1.50. The new note on the price target was released on January 10, 2025, representing the official price target for IGM Biosciences Inc stock. Previously, the target price had yet another drop from $12 to $2, while Morgan Stanley kept a Underweight rating on IGMS stock.
The Price to Book ratio for the last quarter was 111.02, with the Price to Cash per share for the same quarter was set at 2.53.
IGMS stock trade performance evaluation
IGM Biosciences Inc [IGMS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.32. With this latest performance, IGMS shares gained by 1.57% in over the last four-week period, additionally sinking by -80.60% over the last 6 months – not to mention a drop of -78.89% in the past year of trading.
IGM Biosciences Inc [IGMS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and IGM Biosciences Inc [IGMS] shares currently have an operating margin of -6398.81% and a Gross Margin at -243.45%. IGM Biosciences Inc’s Net Margin is presently recorded at -7417.79%.
Return on Equity for this stock declined to -68.22%, with Return on Assets sitting at -68.22%.
Earnings per share (EPS) analysis for IGM Biosciences Inc [IGMS] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IGMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for IGM Biosciences Inc go to 45.66%.
IGM Biosciences Inc [IGMS]: Institutional Ownership
There are presently around $47.52%, or 76.12%% of IGMS stock, in the hands of institutional investors. The top three institutional holders of IGMS stocks are: BAKER BROS. ADVISORS LP with ownership of 4.09 million shares, which is approximately 6.7682%. PRICE T ROWE ASSOCIATES INC /MD/, holding 4.08 million shares of the stock with an approximate value of $$28.0 million in IGMS stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $$22.88 million in IGMS stock with ownership which is approximately 5.5108%.
